Biomedical Engineering Reference
In-Depth Information
37. Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL, Charbonneau F, Cohen E,
Curtis M, Buller CE, Mendelsohn FO, Dib N, Page P, Ducas J, Plante S, Sullivan J, Macko J,
Rasmussen C, Kessler PD, Rasmussen HS (2006) Angiogenic gene therapy in patients with
nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of
AdVEGF(121)
(AdVEGF121)
versus
maximum
medical
treatment.
Gene
Ther
13(21):1503-1511
38. Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H,
Zsebo KM, Hajjar RJ (2009) Calcium Up-Regulation by Percutaneous Administration of Gene
Therapy In Cardiac Disease (CUPID) Trial Investigators.: Calcium upregulation by
percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-
human phase 1/2 clinical trial. J Card Fail 15(3):171-181
39. Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM,
Dittrich H, Hajjar RJ (2011) Calcium Upregulation by Percutaneous Administration of Gene
Therapy in Cardiac Disease (CUPID) Investigators.: Calcium Upregulation by Percutaneous
Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary
gene therapy of sarcoplasmic reticulum Ca2+- ATPase in patients with advanced heart failure.
Circulation 124(3):304-313
40. Losordo
DW,
Dimmeler
S
(2004)
Therapeutic
angiogenesis
and
vasculogenesis
for
ischemic disease. Part I: angiogenic cytokines. Circulation 109(21):2487-2491
41. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, Cattini PA (2007)
Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 12(3-4):267-277
42. Palmen M, Daemen MJ, De Windt LJ, Willems J, Dassen WR, Heeneman S, Zimmermann R,
Van Bilsen M, Doevendans PA (2004) Fibroblast growth factor-1 improves cardiac functional
recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor
receptor, protein kinase C, and tyrosine kinase-dependent mechanism. J Am Coll Cardiol
44(5):1113-1123
43. Kawasuji M, Nagamine H, Ikeda M, Sakakibara N, Takemura H, Fujii S, Watanabe Y
(2000) Therapeutic angiogenesis with intramyocardial administration of basic fibroblast
growth factor. Ann Thorac Surg 69(4):1155-1161
44. Engel FB, Hsieh PC, Lee RT, Keating MT (2006) FGF1/p38 MAP kinase inhibitor therapy
induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial
infarction. Proc Natl Acad Sci USA 103(42):15546-15551
45. Bougioukas I, Didilis V, Ypsilantis P, Giatromanolaki A, Sivridis E, Lialiaris T, Mikroulis D,
Simopoulos C, Bougioukas G (2007) Intramyocardial injection of low-dose basic fibroblast
growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit
myocardium. Cardiovasc Pathol 16(2):63-68
46. Betsholtz C (2004) Insight into the physiological functions of PDGF through genetic studies
in mice. Cytokine Growth Factor Rev 15(4):215-228
47. Lu H, Xu X, Zhang M, Cao R, Brakenhielm E, Li C, Lin H, Yao G, Sun H, Qi L, Tang M,
Dai H, Zhang Y, Su R, Bi Y, Zhang Y, Cao Y (2007) Combinatorial protein therapy of
angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac
function in pigs. Proc Natl Acad Sci USA 104(29):12140-12145
48. Zhao YY, Feron O, Dessy C, Han X, Marchionni MA, Kelly RA (1999) Neuregulin
signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac
myocytes. Circ Res 84(12):1380-1387
49. Bersell K, Arab S, Haring B, Kuhn B (2009) Neuregulin1/ErbB4 signaling induces
cardiomyocyte proliferation and repair of heart injury. Cell 138(2):257-270
50. Lavine KJ, White AC, Park C, Smith CS, Choi K, Long F, Hui CC, Ornitz DM (2006)
Fibroblast growth factor signals regulate a wave of hedgehog activation that is essential for
coronary vascular development. Genes Dev 20(12):1651-1666
51. Pola R, Ling LE, Silver M, Corbley MJ, Kearney M, Blake PR, Shapiro R, Taylor FR,
Baker DP, Asahara T, Isner JM (2001) The morphogen Sonic hedgehog is an indirect
angiogenic
agent
upregulating
two
families
of
angiogenic
growth
factors.
Nat
Med
7(6):706-711
